Neostigmine methyl sulfate
Neostigmine methyl sulfate is a peripherally-acting, reversible acetylcholinesterase inhibitor used to treat myasthenia gravis. It is a research tool for studying cholinergic transmission in vitro and for modeling peripheral cholinergic enhancement in vivo, due to its inability to cross the blood-brain barrier.
Product Specifications
CAS Number
51-60-5
Product Name Alternative
Inhibitor, Hodostin, inhibit, Normastigmin, Neostigmine methyl, Neostigmine methyl sulfate, Neostigmine methyl Sulfate, Cholinesterase (ChE), AChE, AChR, Syntostigmin
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.34% (May vary between batches)
Solubility
DMSO:55 mg/mL (164.48 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.98 mM) ; H2O:200.4 mM
Smiles
C1 (cc (ccc1) [N+] (C) (C) C) OC (=O) N (C) C.S (=O) (=O) (OC) [O-]
Molecular Formula
C13H22N2O6S
Molecular Weight
334.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
